DEFERASIROX
Active substance: deferasirox
GRANULE · DEFERASIROX 360 mg/1
United StatesActive
Marketing holder: Camber Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- DEFERASIROX · 360 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 22 |
|
| EU 3 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3541-7ce5-9199-d068f6af414c,01a120c3-3d8a-7a57-9fc3-790fbf7cb5df,01a120c3-3f86-733d-aee1-b936d6e5abd4,01a120c3-416a-742c-8895-94443074bf0e,01a120c3-4197-79d6-a4c2-e62efd4f214f;count=21 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2970-725c-b8aa-7e90c2af8453,01a1208c-4820-7a96-90b9-8407653ebfda,01a1208c-4fbc-7a96-9eb8-adfa36c6bc11,01a1208c-4fc4-74c7-aaec-c9253321ef97,01a1208c-5b93-7850-9258-686a81c9adb3;count=94 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 31722-031
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 31722-031 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 31722-031 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 31722-031 · Verified 2026-10-09 · open in source